Tanzania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Tanzania Pharmaceuticals and Healthcare Report

Tanzania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Tanzania Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
60 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In our Q--- Pharmaceutical Risk/Reward Index (RRI) Tanzania s score of --.- out of --- marks a slight worsening from its score last quarter of --.-, and lowers its position by one rank to --rd place out of -- countries analysed in the whole Middle East and Africa (MEA) region. A sizeable counterfeiting industry, poor healthcare funding, corruption, regulatory environment deficiencies and a number of other issues will conspire to keep Tanzania in a similarly lowly position in the MEA matrix. ...In our Q--- Pharmaceutical Risk/Reward Index (RRI) Tanzania s score of --.- out of --- marks a slight worsening from its score last quarter of --.-, and lowers its position by one rank to --rd place out of -- countries analysed in the whole Middle East and Africa (MEA) region. A sizeable counterfeiting industry, poor healthcare funding, corruption, regulatory environment deficiencies and a number of other issues will conspire to keep Tanzania in a similarly lowly position in the MEA matrix. In particular, issues relating to patent approvals and the regulatory system remain a major issue for foreign research-based pharmaceutical players. ...In particular, issues relating to patent approvals and the regulatory system remain a major issue for foreign research-based pharmaceutical players. Nevertheless, in comparison with many other African markets, Tanzania offers more commercial promise and a more stable overall business environment.

...The pharmaceuticals market in Tanzania is forecast to grow strongly over the next few years, largely due to an increasing disease burden. The government s interest in developing the pharmaceutical sector. High rate of population growth and urbanisation will continue to support pharmaceutical market growth, creating revenue earning opportunities for drugmakers. The government s interest in developing the pharmaceutical sector. ...Limited public healthcare provision and staff shortages. Many Tanzanians lack access to health facilities due to financial reasons or because of sparse healthcare infrastructure in rural areas.

...BMI View: Tanzania s pharmaceutical market will continue to suffer from a lack of domestic production as the majority of the country s medicine needs remain sourced from abroad. Despite government efforts to boost local pharmaceutical production, generic drugmakers, largely from India will dominate Tanzania s pharmaceutical landscape. ...BMI View: Tanzania s pharmaceutical market will continue to suffer from a lack of domestic production as the majority of the country s medicine needs remain sourced from abroad. Despite government efforts to boost local pharmaceutical production, generic drugmakers, largely from India will dominate Tanzania s pharmaceutical landscape. Moreover, supply chain issues will deter direct investment prospects by multinational drugmakers. ...

  
Source:
Document ID
2049-0143
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Tanzania Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Tanzania-Pharmaceuticals-and-Healthcare-Report-2026-1349>
  
APA:
Business Monitor International - Industry Reports. (2016). Tanzania Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Tanzania-Pharmaceuticals-and-Healthcare-Report-2026-1349>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.